How Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?
Harvard Data Science Review Podcast
00:00
The Role of the NIH in Longitudinal Studies
There's so many people that are on these medications. We're not looking at a rare disease like John deals with it. That, you know, really that shouldn't be a barrier to conducting these studies. And then this data needs to be collected somewhere centrallySo that we can learn more about the side effect profile of these medications.
Transcript
Play full episode
